Charité neuroscientist Prof. Dr. Surjo Soekadar awarded with ERC Proof of Concept (ERCPoC) grant after NeuroCure/SPARK-BIH funding
EpiBlok Therapeutics GmbH is developing a gene therapy for epilepsy
Dr. Angelika Vlachou, Principal at High-Tech Gründerfonds (HTGF), supported 25 translational SPARK project teams with a dedicated hands-on Pitch Training Workshop.
APPLY NOW! We offer funding and coaching to support your translational project.
SPARK-BIH and NeuroCure organized a second Design Thinking workshop.
After the successful implementation of the NeuroCure/SPARK program, NeuroCure and SPARK-BIH prolong their collaboration and will run a second call for projects.
Researchers led by our SPARKee Ulrike Stein of the ECRC and Robert Preißner of Charité report in "Clinical and Translational Medicine" that statins inhibit a gene that promotes cancer cell metastasis.
NeuroCure grants funding extension to the four NeuroCure/SPARK-BIH teams for an additional year.
We are a mentoring network aiming to accelerate the translation of academic inventions into clinically relevant drugs, diagnostics and medical devices.
Validate your research findings and translate them into therapies, products or services to help patients.
Share your expertise with our SPARKees and participate in our program as SPARK advisor.
SPARK-BIH is a member of the SPARK Global network